Atrandi Biosciences is an emerging developer and provider of innovative microfluidic and high-throughput screening solutions. Our novel technology platforms enable researchers to gain unparalleled insights into the biology of single cells, offering immediate applications in single-cell sequencing, drug and antibody discovery, functional metagenomics, microbial analysis, directed evolution, and synthetic biology. With systems installed in leading academic and commercial laboratories around the world, Atrandi Biosciences is committed to provide simple-to-adopt and easy-to-use single-cell analysis solutions that accelerate your research.

Basgenbio is a clinico-genomic cohort-based R&D company with K-Biobank, which contains blood samples from 156,000subjects, along with their clinical and lifestyle information, with a maximum follow-up period of 18years. Notably, we have 8,662 cancer and 75,424 major chronic disease events.

Drawing on our experience in building an exclusive cohort data, Basgenbio also work on establishing a sarcopenia cohort and a rare disease biobank in collaboration with pharmaceutical companies, universities, and national associations.

Basgenbio also conducts clinical trial simulations with AI-based bioinformatics aiming at increasing the efficiency of drug development. It involves drug repurposing, drug combination, and the identification and validation of drug targets.

Basgenbio has exclusively accumulated imaging, clinical, and lifestyle data from five specialized spine and joint hospitals in South Korea. Specifically, among the imaging data, there are over 10.5 million X-ray images, over 690,000 MRI images, and among the clinical data, there are more than 26 million instances of prescription data and over 15.5 million instances of lab test data that have been established.

Through the integration of imaging data and omics data, we develop a solution and it will evolve into a comprehensive care platform for musculoskeletal disorders covering prevention, diagnosis, treatment planning, and prognosis prediction.

BeeKeeperAI is accelerating the availability of AI technologies that will redefine the future of healthcare through its zero-trust multi-party collaboration platform, EscrowAI. We create a hive of benefits protecting the intellectual property of models as they travel to the secure environment of data stewards to sightlessly compute, within a trusted execution environment, on protected health information. Both IP and PHI remain protected at rest, in transit, and during compute resulting in streamlining the approvals process by as much as 80%. For more information check out BeeKeeperAI or stop by to hear the buzz!

BigOmics Analytics is a Swiss biodata analytics company that develops software for the visualization and exploration of omics data with the aim of accelerating data analysis processes in life sciences and significantly reducing discovery time.
Our flagship platform is Omics Playground, which provides highly interactive and user-friendly visualization tools for understanding RNA-seq and proteomics data. The platform helps bioinformaticians, biologists and teams reduce the time spent on data analysis and free up more time for discovery.

With more than 18 analysis modules and 150 interactive plots, Omics Playground uses best-in-class methods and algorithms for each analysis step, ensuring robust and reproducible results."

BioAge is a clinical-stage biotechnology company developing a pipeline of treatments to extend healthy lifespan by targeting the molecular causes of aging. The company uses its discovery platform, which combines quantitative analysis of proprietary longitudinal human samples with detailed health records to map out the key molecular pathways that impact healthy human aging. By targeting the mechanisms of aging with a large and mechanistically diverse portfolio of drugs, BioAge is unlocking opportunities to treat or even prevent age-related disease in entirely new ways. BioAge's growing portfolio includes multiple assets targeting muscle, immune, and brain aging.

biomodal is an omics based life-sciences technology and analytics company delivering products that bring the dynamism of our ever-changing biology into focus. biomodal's duet multiomics solution enables more epigenetic information from a single, low input DNA library without complex, resource intensive bioinformatics or harsh chemical treatment. biomodal's single-base-resolution, phased sequencing approach unlocks the combinatorial power of genetic and epigenetic information in one workflow, elucidating greater biological insight within the fields of cancer, neurodegenerative disease, and ageing.

BostonGene’s mission is to power healthcare’s transition to personalized medicine using our AI-based molecular and immune profiling to improve the standard of care, accelerate research, and reduce the overall cost of cancer care. BostonGene’s tests reveal key drivers of each tumor, including immune microenvironment properties, actionable mutations, biomarkers of response to diverse therapies, and recommended therapies. Through these comprehensive analyses, BostonGene’s tests generate a personalized roadmap for therapeutic decision-making for each cancer patient. For more information, visit BostonGene at http://www.BostonGene.com.

Complete Genomics is a pioneering life sciences company, founded in 2005, offering a comprehensive portfolio including sample extraction, library preparation, lab automation, and sequencing platforms. Our mission is to drive genomics forward with complete sequencing solutions that improve lives and has published + 4,000 publications across a wide array of applications.

Covaris’ groundbreaking Adaptive Focused Acoustics® (AFA®) technology accelerates discoveries in life sciences in labs focused on extraction, purification, and analysis of biomolecules from complex biological matrices. AFA is the gold standard for shearing DNA and RNA in Next Generation Sequencing (NGS) laboratories and has applications across other multiomics workflows including FFPE sample analysis, cfDNA extraction, ChIP, proteomics, epigenomics, cell lysis, and compound management. Covaris’ instruments offer a high level of scalability including automated sample processing with variable sample inputs. For more information, please visit www.covaris.com

Cytiva and Pall Life Sciences have come together to deliver the breadth, depth, and scale researchers and biopharma need to advance future therapeutics—from discovery to delivery. Together, as Cytiva, we supply the tools and support our customers need to work better, faster, and safer, leading to the delivery of transformative medicines to patients. Our combined portfolio includes well-recognized names such as Allegro™, Supor™, iCELLis™, and Kleenpak™, in addition to ÄKTA™, Amersham™, Biacore™, FlexFactory™, HyClone™, MabSelect™, Sefia™, Whatman™, and Xcellerex™. Visit cytiva.com to learn more.

Diamond Age Data Science is an outsourced bioinformatics department for biotech and pharmaceutical companies that works across genomics, single cell and advanced transcriptomics, biostatistics, machine learning, multi-omics, and pipeline and cloud engineering.

Scientist founded and led since 2017, Diamond Age’s experienced consultants have collaborated with 70+ client companies to solve complex data analysis and engineering problems. Our experience includes omics data analysis, methods development, data mining, FDA reporting and pipeline engineering. We also build custom tools for biomarker discovery and development, patient selection, target ID, platform builds, and more.

We are trained life scientists, data scientists, engineers, and statisticians who will work with you to design and execute analyses that meet your scientific goals. Once we have results we work with you to understand the analysis, refine hypotheses, tune and adjust the analysis, and help you design your next experiment.

Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets. Founded in 2017, our headquarters is located in San Diego, California, with additional operations located in the San Francisco Bay area. Our mission is to empower the scientific community with more freedom and flexibility to accelerate our collective impact on humanity.

For our first product AVITI is a modular and high-performing DNA sequencing platform that will deliver high-quality data, workflow flexibility and make next-generation sequencing technology more accessible. Our proprietary approach to improving the signal-to-noise ratio allows us to provide groundbreaking innovations in surface chemistry, instrumentation, and biochemistry to drastically decrease the run cost and capital cost while delivering high sequencing data quality.

Eremid is your genomics contract research organization, offering specialist expertise in Human Health, Nutrition, and AgBiotech, delivering high quality research-enhancing data through customized, collaborative projects. Access our world class scientific staff, CLIA-certified lab, and cutting-edge genomics systems and automation to achieve higher quality science. Our unmatched facility combines a highly experienced team of genomics scientists and a broad expertise across multiple areas and cutting-edge technologies from Illumina, Pacific Biosciences, Oxford Nanopore Technology, Thermo Fisher, 10x Genomics, and NanoString.
Our team is ready to help you design your project and select the best platforms and workflows for your analysis.

From study design and sample preparation to data analysis, integration and interpretation - our contract research services are designed with scalability, quality, and reproducibility in mind.

Our labs are equipped with multiple platforms enabling different project sizes and applications to be run quickly and efficiently, supported by full extraction capability for multiple sample types.

Gene Tools, LLC designs and manufactures Morpholino antisense oligos. Morpholino oligos bind to complementary RNA and prevent binding of other macromolecules; they can knock down gene expression, modify RNA splicing and inhibit miRNA activity and maturation, among other applications. Morpholinos are used in embryos, in cell culture and, as Vivo-Morpholinos, in adult animal models.

Morpholinos have been approved by the FDA for human use. Eteplirsen, golodirsen, casimersen and viltolarsen are being sold and administered to people with Duchenne muscular dystrophy. Morpholinos from Gene Tools are research-grade, not GMP.

Our scientists developed novel cytosolic delivery systems like 'Endo-Porter' for cultured cells and ‘Vivo-Morpholinos’ for both cultures and in vivo delivery. Established delivery technologies can deliver Morpholinos into cultures, embryos and animals making Morpholinos the best tools for genetic studies and drug target validation programs.

Backed by Ph.D.-level customer support, Gene Tools sells research quantities of Morpholinos world-wide.

Genome Québec offers high-quality services to the scientific community and has become a resource for research initiatives in human health, forestry, infectious diseases, agriculture, and sustainable development. Ambitious projects in recent years are a testimony of the ability of GQ to provide reliable, comprehensive services and data of exceptional quality in the pursuit of various genomics studies. GQ provides complete DNA and RNA analysis services including sequencing, genotyping and nucleic acid extraction supported by a solid infrastructure, tools (Nanuq) and unique expertise in bioinformatics.
Génome Québec’s mission is to catalyze the development and excellence of genomics research and promote its integration and democratization. It is a pillar of the Québec bioeconomy and contributes to Québec’s influence and its social and sustainable development.
Genomics-driven innovations improve health care service delivery, support agrifood, environmental and forest management practices and enhance public policies.

MedBioInformatics Solutions are the creators of DISGENET plus. We’re leveraging genetics and AI to support precision medicine.
Human genetics offers the potential to identify new therapeutic targets and prioritize decision-making throughout the process of drug discovery and development.
The commercial offering, DISGENET plus, is a disease genomics platform with the world’s most comprehensive catalog of genes and variants associated with human diseases and phenotypes to unlock the potential of genomics for drug R&D and clinical genomics.

DISGENET plus:
Brings the power of AI and genetics together
Integrates all the information on genes and genomic variants associated with every human disease in a single resource
Based on the community-recognized DisGeNET platform, cited by more than 2500 publications and one of the ELIXIR* Recommended Interoperability Resources.

Coverage of the full spectrum of human diseases as well as normal and abnormal traits, and adverse drug events.
Interoperable resource supporting a variety of applications in genomic medicine and drug R&D.

NanoString Technologies, a leader in spatial biology, offers an ecosystem of innovative discovery and translational research solutions, empowering our customers to map the universe of biology. The GeoMx® Digital Spatial Profiler, cited in more than 160 peer-reviewed publications, is a flexible and consistent solution combining the power of whole tissue imaging with gene expression and protein data for spatial whole transcriptomics and proteomics from one FFPE slide. The CosMx™ Spatial Molecular Imager (SMI) is an FFPE-compatible, single-cell imaging platform powered by spatial multiomics enabling researchers to map single cells in their native environments to extract deep biological insights and novel discoveries from one experiment. The AtoMx™ Spatial Informatics Platform (SIP) is a cloud-based informatics solution with advanced analytics and global collaboration capabilities, enabling powerful spatial biology insights anytime, anywhere. The CosMx SMI and AtoMx SIP platforms are expected to launch in 2022. At the foundation of our research tools is our nCounter® Analysis System, cited in more than 7,000 peer-reviewed publications, which offers a secure way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision. For more information, visit www.nanostring.com.

Novogene is a leading provider of genomic services and solutions with cutting-edge NGS and bioinformatics expertise and the largest sequencing capacity in the world.

Novogene delivers unsurpassed data quality to support our customers’ research goals. We are a world leader in NGS services, with thousands of employees and multiple locations across the globe. Novogene has strong scientific expertise and experience with 69 NGS-related patents, as well as over 16,000 SCI articles with a total impact factor of more than 100,000, including publications in first tiers journals such as Cell, Nature, and Science.

As the largest NGS service provider headquartered in Beijing with branches in Hong Kong China, US, UK, Singapore, Netherlands, and Japan, Novogene was founded in 2011 and has been growing rapidly over the past few years. Novogene has genomic sequencing labs in the US, China, Singapore and the UK.

Parse Biosciences is a Seattle-based company with the mission of accelerating progress in human health and scientific research. At the core of our company is our pioneering approach for single cell sequencing. Single cell sequencing has already enabled groundbreaking discoveries which have led to new understandings of cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system. At Parse Biosciences, we are providing researchers with the ability to perform single cell sequencing with unprecedented scale and ease.

Genetic advances are rapidly entering our lives - during a doctor’s visit, when taking an ancestry test, in the voting booth, in deciding what foods to eat, and more. At PGED, public engagement about genetics is crucial to fostering a safe, equitable, and ethical path forward, ensuring individuals are empowered to make informed decisions. Based in the Department of Genetics at Harvard Medical School, PGED creates welcoming spaces for constructive conversations about genetics - including real-world applications, personal and family decisions, and broader societal impacts. We seek to reach people where they are through a people-centered, inclusive, and reciprocal approach aligned with evidence-based best practices in science engagement. Our team creates free resources such as curricula and training workshops, produces public engagement programming, advises filmmakers and TV producers, organizes Congressional briefings, and facilitates discussions with faith communities. To connect with us, go to www.pged.org.

At PreventionGenetics, we are passionate about human genetics and its power to improve lives.

Located in Marshfield, WI, PreventionGenetics was founded in 2004 and acquired in 2022 by global cancer diagnostics leader, Exact Sciences. PreventionGenetics is a CLIA and ISO 15189:2012 accredited laboratory, delivering high-quality genetic testing at fair prices with exemplary service to clinicians and researchers and around the world.

We provide tests for nearly all clinically relevant genes including our powerful and comprehensive whole-genome sequencing test, PGnome®, and whole-exome sequencing test, PGxome®.

In the changing landscape of genetic testing, our quality and commitment to clinicians, researchers and patients remains unchanged. We stay on the forefront of clinical genetics and consistently expand and update our test menu, introduce new technologies and increase the efficiency of our processes.

Quantum-Si is revolutionizing the growing field of proteomics through its suite of technologies that are powered by a first-of-its-kind semiconductor chip designed to enable single-molecule, next-generation protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Our mission is to democratize proteomic analysis so that every researcher, scientist and clinician can better understand the role of proteins in cell biology and disease and use this knowledge to improve human health.
We provide a convenient solution that reveals in-depth, proteomic insight in an easy-to-use accessible workflow. Our technology allows them to expand their understanding of cell biology and disease by uncovering what is there and not what could be there, which opens the door to the development of new diagnostics and discovery of novel life-saving drugs.

RAN Biotechnologies provides consumables, kits and devices for microfluidics in general and for high-throughput multiomics in particular.
Examples of RAN biotech’s products:

- Hydrogel Beads: including barcoded / dissolvable / superparamagnetic beads; they are used in proven technologies such as InDrop, Drop-Seq, Seq-Well, CEL-seq, Single-Cell RNA sequencing, …. The mechanical properties of these beads support their use in conventional microfluidics, wells and particle-templated emulsification and can be adapted to custom workflows.

- FluoroSurfactants for droplet microfluidics; Emulsion Breaking oils; and Microfluidic Chip Coating

- Chip-Free Engineered Droplet Generation kit (NoChipDrop kitTM): optimized for rapid generation of stable pL-size droplets without the need for a microfluidic setup.

- PDMS Microfluidic Chips.

- Flow Controllers: Introducing theBOXTM, an innovative and pioneering small, portable, affordable and easy-to-use flow controller. Stop by our booth to check it out!

- Micro and Nanomaterials for Capturing and Concentrating Microbes.

Contact us at info@ranbiotechnologies.com; 001 (833) 726-2661.

Founded in 2012 as a data curation company, Rancho Biosciences has been helping clients in life sciences research with a range of F.A.I.R. related services such as data harmonization & standardization, data modeling, ontology development & management, data governance, bioinformatics analysis, pipeline and other software development, including visualizations. In February 2022 Rancho launched the pre-competitive Single Cell Data Science consortium to harmonize publicly available single cell datasets. It is now in its second year and is supported by 6 Pharma/biotech companies.

Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is pushing the limits of what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics, and more. With a robust global network and localized agility, we serve a diverse range of organizations from pharmaceutical and biotech, to clinical labs, academia, and governments. Together with our customers and partners, we are united in impact, embracing the impossible to improve lives everywhere.

Sage Science specializes in developing electrophoretic sample preparation technologies for life science research. Sage’s products feature the Pippin™ line of DNA size selection systems which are widely used in the construction of DNA sequencing libraries.
Pippin™ instruments enable researchers to collect user-adjustable DNA size distributions which can be crucial to enhancing genomic studies. For short-read sequencing, the technology provides flexibility and accuracy in sizing to meet specific experimental needs. For long-read sequencing, it provides an outstanding rejection of small fragments which yield longer average read lengths and more meaningful results.
Sage Science’s automated preparative electrophoresis approach offers greater control over DNA fragment sizes than any other method, leading to enhanced data quality and improved downstream analysis in genomics research.

seqWell unlocks the full potential of your NGS workflow via our revolutionary library prep technology that shaves hours from your workflow. Multiplex 100’s to 1,000’s of samples and simultaneously normalize your samples, all in a simple, easy-to-use protocol that saves time and doesn’t sacrifice results. seqWell invites you to visit us in our booth to discuss how we can improve your lab’s efficiency. Ask us about our newest products: ExpressPlex™ Library Prep Kit designed for quick turnaround of plasmid, amplicon, or synthetic construct sequencing, purePlex™ UDI-based library prep kit, and Tagify™ custom-loaded Tn5 transposases. Collaborate with us on your next project and see what a difference we can make!

Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies. The commercially available G4 Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. In development, the PX system leverages Singular’s proprietary sequencing technology, applying it as an in-situ readout to look at RNA and proteins in single cells and tissue. With these products, Singular Genomics’ mission is to empower researchers and clinicians to advance science and medicine.

At Tecan we are driven to improve people’s lives and health. We do this by empowering our customers to scale healthcare innovation globally from life science to the clinic.

We collaborate with our customers in healthcare and the life sciences, from early-stage innovation through project implementation and beyond. We deliver the products, services and solutions that make lab processes and medical procedures precise, reproducible and compliant. This leads to scalable outcomes that are further reaching and ever more valuable to humankind.

Thermo Fisher Scientific is the world leader in serving science. Customers worldwide trust our tools and solutions to help them accelerate innovation and enhance productivity. Together, we are making advancements that make a real difference. We do that by providing an unmatched combination of innovative technologies, purchasing convenience, and comprehensive support through product and service brands

Watershed Bio brings together top-of-the-line experts in software engineering, bioinformatics, and biology to integrate the critical components for successful data-driven discovery. We packaged them into Omics Bench, the unified solution for omics data analysis, to enable you to drive your therapeutic product to market at record speed. This powerful platform, built specifically for large biological data, was designed to enable the ultra-fast data processing necessary to get your product to market at record speed. Equipped with the flexibility of customizable template analysis applications as well as de novo workflow builds, state-of-the-art security and data tracking, and dedicated support from our PhD-level bioinformatics and computational biology teams, Omics Bench is an unparalleled force in biological data analysis.

Zifo is a global specialist scientific and process informatics service provider working across research, development, manufacturing and clinical domains with expertise in over 90 partner technologies and platforms. We serve customers from Pharma/Biotech/CRO, Industrial chemicals and Food & Bev, to Consumer Goods and Oil and Gas. Our “Glocal” approach leverages remote delivery to ensure cost-effective delivery and solutions coupled with dedicated local support to ensure engagement, success and quality.